Atlas Trials

Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

Clinical trial NCT04196231 · COMPLETED

Trial details

NCT number
NCT04196231
Sponsor
University of Campania Luigi Vanvitelli
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2019-11-27
Primary completion
2020-09-30
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.